A closer look at the Wyzo high-speed pick-and-place sidebot

The Wyzo robot features a human machine interface designed for ease of use.

The robotics firm Wyzo (Ecublens, Switzerland) recently debuted a novel pick-and-place sidebot, which is suitable for various uses, including lightweight applications within pharmaceutical facilities. Pharmaceutical Processing World recently profiled the robot, which can support up to 80 picks per minute.  

To learn more about the robot, we reached out to Wyzo CEO Frank Souyris, who describes the types of pharmaceutical applications the technology can handle. Souyris also provides information on how the robot can operate side-by-side with humans without protective barriers or performance compromises. 

What kind of pharmaceutical applications do you envision for the Wyzo robot? 

Souyris: Thanks to the high-tech robotic arm and built-in or external vision systems, the Wyzo sidebot is suitable for any type of pharmaceutica…

Read more
  • 0

Swiss startup Wyzo debuts novel robot that supports pharma applications

The robotics firm Wyzo (Ecublens, Switzerland) has launched what it deems the world’s first pick-and-place sidebot. Supporting pharmaceutical production line applications, the Wyzo robot can work side-by-side with humans without traditional protective barriers.

The robot also supports up to 80 picks per minute.

The Wyzo is also compatible with standard grippers.

The company says that the Wyzo robot occupies one-sixth of the space of a traditional industrial robot. Its footprint is less than 0.5 m2, and the robot measures 1.80 m in height. The small size enables manufacturers to relocate the robot from one workstation to another as needed. Workers can transport it through standard doors or via elevators.

The Wyzo uses sensor technology to monitor nearby human activity. Its software enables it to reduce its operating speed when a human is nearby.

Wyzo also says the robot is easy to program even for operators without prior experience in automa…

Read more
  • 0

Improving vaccine production with advanced analytics

mRNA vaccine picture courtesy of Wikipedia

This scientific, engineering and logistical achievement that is the COVID-19 vaccine is a feat unparalleled. It’s the perfect example of human ingenuity and how modern advancements can make a difference. A lot of credit, however, has to go to the rise of Industry 4.0 and the use of digital technologies like automation, computer science, and advanced analytics. In fact, automated operations, process simulation, and self-service analytics have helped pharmaceutical production processes become more agile and efficient, contributing to increased production capacity and product quality. This solution has become the production and quality control game-changer by making pharmaceutical companies more adaptive and responsive, thus improving operational processes.

Using time-series data to improve operational performance

Captured from sensors throughout the production line, t…

Read more
  • 0

Pharma’s been slow to adopt Industry 4.0 — but that could change

Image courtesy of Wikipedia

The pharma industry has been relatively slow to embrace concepts such as Industry 4.0, but COVID-19 is serving as a catalyst for sweeping changes within the industry.

The philosophy has roots in a German framework that prioritizes digitization to drive manufacturing efficiency, promising that cyber-physical systems will usher in the next industrial revolution. The Industry 4.0 framework spans connectivity, analytics and AI and integrated automation technologies.

But the deployment of Industry 4.0–inspired technologies has been uneven in the pharma industry. “The industry is pretty cautious,” said John Younes, COO of Litmus Automation, the developer of an industrial edge computing platform.

Get the full story from our sister site, Pharmaceutical Processing World. 

Read more
  • 0